2025-08-01 - Analysis Report
Okay, here's a report analyzing PepsiCo Inc. (PEP) based on the provided data.

**PepsiCo Inc. (PEP) Analysis**

PepsiCo Inc. is a global food and beverage company.

**1. Relative Performance vs. S&P 500 (VOO)**

*   **PEP Cumulative Return:** 19.52%
*   **VOO (S&P 500) Cumulative Return:** 83.19%
*   **Absolute Divergence:** -69.7% (PEP significantly underperformed VOO)
*   **Relative Divergence:** 6.4% (PEP's underperformance is near its historical worst relative to VOO within the dataset's range)

**Alpha/Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap (B) |
|------------|----------|----------|---------|--------|---------|
| 2015-2017  | 8.0%     | 0.0%     | 5.0%    | -0.1   | 164.2   |
| 2016-2018  | 5.0%     | 62.5%    | 9.0%    | 0.1    | 151.3   |
| 2017-2019  | 28.0%    | 62.5%    | 6.0%    | 0.1    | 187.1   |
| 2018-2020  | 35.0%    | 62.5%    | 8.0%    | 0.1    | 203.0   |
| 2019-2021  | 53.0%    | 61.1%    | 4.0%    | 0.0    | 237.8   |
| 2020-2022  | 12.0%    | 61.1%    | 5.0%    | 0.0    | 247.3   |
| 2021-2023  | 10.0%    | 61.4%    | -10.0%   | 0.3    | 232.5   |
| 2022-2024  | -35.0%   | 61.4%    | -61.0%   | 0.3    | 208.2   |
| 2023-2025  | -21.0%   | 70.2%    | -70.0%   | 0.4    | 188.8   |

*   **CAGR Trends:** Fluctuating CAGR, with recent periods showing negative returns.
*   **MDD:** High Maximum Drawdown (MDD) in recent periods indicates significant risk.
*   **Alpha:** Alpha has become increasingly negative, suggesting underperformance relative to the market.
*   **Beta:** Beta is low (close to 0), suggesting PEP's price is not strongly correlated with the market.

**2. Recent Price Action:**

*   **Current Price:** $137.92
*   **Previous Close:** $142.86
*   **Change:** -$3.46 (Notable drop)
*   **5-day Moving Average:** $141.94
*   **20-day Moving Average:** $139.52
*   **60-day Moving Average:** $133.80

*   The current price is below the 5-day and 20-day moving averages, suggesting a short-term downtrend.  The price is still above the 60-day average, indicating a potentially mixed longer-term trend.  The significant price drop from the previous close indicates selling pressure.

**3. Technical Indicators:**

*   **MRI (Market Risk Indicator):** 0.33 (Low Risk)
*   **RSI:** 53.85 (Neutral)
*   **PPO:** -0.21 (Slightly bearish)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33) (Cash Ratio: 0% on 2025-07-03) - This recommends buying using 80% of available cash.
*   **20-day Relative Divergence Change:** -2.2 (Short-term decrease in relative performance)
*   **Expected Return:** -125.5% (Significant negative expected return relative to the S&P 500 for a long-term investment)

*   The MRI indicates a low-risk environment. The RSI is neutral, suggesting neither overbought nor oversold conditions. The negative PPO suggests bearish momentum. The negative Expected Return is concerning. The hybrid signal recommends cautiously buying stocks, but based on the recent price drop the recommendation might change.

**4. Recent News & Significant Events:**

*   **Volatility:** The stock has shown notable volatility.
*   **Analyst Discussions:** Analysts are discussing recent performance and outlook, highlighting both risks and opportunities.
*   **Major Business Developments/Regulatory Changes/Market Events:** PEP recently made headlines due to major events.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-07-17 | 0.92 | $22.73B    |
| 2025-04-24 | 1.34 | $17.92B    |
| 2024-10-08 | 2.13 | $23.32B    |
| 2024-07-11 | 2.24 | $22.50B    |
| 2025-07-17 | 2.24 | $22.50B    |

*   **EPS:** EPS has fluctuated, but the most recent EPS is lower than previous quarters, signaling a potential reduction in profitability or increased costs.
*   **Revenue:** Revenue has also fluctuated, indicating variability in sales performance.

**6. Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $22.73B   | 54.66%        |
| 2025-03-31   | $17.92B   | 55.77%        |
| 2024-12-31   | $27.78B   | 52.56%        |
| 2024-09-30   | $23.32B   | 55.42%        |
| 2024-06-30   | $22.50B   | 55.92%        |

Capital and Profitability:

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $18.42B   | 6.86%     |
| 2025-03-31   | $18.39B   | 9.97%     |
| 2024-12-31   | $18.04B   | 8.44%     |
| 2024-09-30   | $19.45B   | 15.06%    |
| 2024-06-30   | $19.45B   | 15.85%    |

*   **Revenue:** Revenue shows some fluctuation.
*   **Profit Margin:** Profit margins are relatively stable, but the most recent quarter shows slight decrease compared to other quarter.
*   **Equity:** Equity has remained relatively stable.
*   **ROE:** ROE has decreased significantly in the most recent quarters compared to the older one, which indicates reduced returns on equity.

**7. Summary Analysis:**

*   **Underperformance:** PEP has significantly underperformed the S&P 500, with a negative relative divergence.
*   **Technicals:** Recent price action is bearish, with the price below short-term moving averages. Technical indicators are mixed, with a neutral RSI but a negative PPO.
*   **Earnings:** The latest EPS is lower than in previous quarters, while revenue has fluctuated.
*   **Financials:** Profit margins are relatively consistent, but ROE has decreased recently, suggesting less efficient use of equity.
*   **News:** Recent news indicates volatility and analyst concern, possibly related to company events.
*   **Risk:** While the MRI indicates a low-risk market environment, the specific indicators for PEP suggest caution. The high MDD values point to potential for significant loss.

**Overall Recommendation:**

Based on this data, a cautious approach is warranted. While the MRI suggests a generally low-risk market, PEP's underperformance, declining ROE, recent price drop, and negative future return are red flags. Further research into the specific events driving the volatility and the company's plans to improve performance is necessary before considering an investment. The current data leans toward avoiding investment or reducing existing positions.
